van Zelst-Stams WA - Search Results

1

Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.

Dekker N, van Rossum LG, Van Vugt-van Pinxteren M, van Stiphout SH, Hermens RP, van Zelst-Stams WA, van Oijen MG, Laheij RJ, Jansen JB, Hoogerbrugge N. Dekker N, et al. Eur J Cancer. 2011 Jul;47(10):1571-7. doi: 10.1016/j.ejca.2011.01.022. Epub 2011 Feb 28. Eur J Cancer. 2011. PMID: 21367600 Free article.

2

DNA-testing for BRCA1/2 prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct.

Sie AS, Spruijt L, van Zelst-Stams WA, Mensenkamp AR, Ligtenberg MJ, Brunner HG, Prins JB, Hoogerbrugge N. Sie AS, et al. BMC Womens Health. 2012 May 8;12:12. doi: 10.1186/1472-6874-12-12. BMC Womens Health. 2012. PMID: 22569005 Free PMC article.

3

Focusing on patient needs and preferences may improve genetic counseling for colorectal cancer.

Salemink S, Dekker N, Kets CM, van der Looij E, van Zelst-Stams WA, Hoogerbrugge N. Salemink S, et al. J Genet Couns. 2013 Feb;22(1):118-24. doi: 10.1007/s10897-012-9519-5. Epub 2012 Aug 23. J Genet Couns. 2013. PMID: 22914993 Free PMC article.

4

Familial colorectal cancer risk assessment needs improvement for more effective cancer prevention in relatives.

Dekker N, Hermens RP, Nagengast FM, van Zelst-Stams WA, Hoogerbrugge N; RISCO study group. Dekker N, et al. Colorectal Dis. 2013 Apr;15(4):e175-85; discussion p.e185. doi: 10.1111/codi.12117. Colorectal Dis. 2013. PMID: 23451840

5

Easy-to-use online referral test detects most patients with a high familial risk of colorectal cancer.

Dekker N, Hermens RP, Mensenkamp AR, van Zelst-Stams WA, Hoogerbrugge N. Dekker N, et al. Colorectal Dis. 2014 Jan;16(1):O26-34. doi: 10.1111/codi.12407. Colorectal Dis. 2014. PMID: 24034789

6

More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling.

Sie AS, van Zelst-Stams WA, Spruijt L, Mensenkamp AR, Ligtenberg MJ, Brunner HG, Prins JB, Hoogerbrugge N. Sie AS, et al. Fam Cancer. 2014 Jun;13(2):143-51. doi: 10.1007/s10689-013-9686-z. Fam Cancer. 2014. PMID: 24068317

7

Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors.

Mensenkamp AR, Vogelaar IP, van Zelst-Stams WA, Goossens M, Ouchene H, Hendriks-Cornelissen SJ, Kwint MP, Hoogerbrugge N, Nagtegaal ID, Ligtenberg MJ. Mensenkamp AR, et al. Gastroenterology. 2014 Mar;146(3):643-646.e8. doi: 10.1053/j.gastro.2013.12.002. Epub 2013 Dec 10. Gastroenterology. 2014. PMID: 24333619

8

Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.

Bancroft EK, Page EC, Castro E, Lilja H, Vickers A, Sjoberg D, Assel M, Foster CS, Mitchell G, Drew K, Mæhle L, Axcrona K, Evans DG, Bulman B, Eccles D, McBride D, van Asperen C, Vasen H, Kiemeney LA, Ringelberg J, Cybulski C, Wokolorczyk D, Selkirk C, Hulick PJ, Bojesen A, Skytte AB, Lam J, Taylor L, Oldenburg R, Cremers R, Verhaegh G, van Zelst-Stams WA, Oosterwijk JC, Blanco I, Salinas M, Cook J, Rosario DJ, Buys S, Conner T, Ausems MG, Ong KR, Hoffman J, Domchek S, Powers J, Teixeira MR, Maia S, Foulkes WD, Taherian N, Ruijs M, Helderman-van den Enden AT, Izatt L, Davidson R, Adank MA, Walker L, Schmutzler R, Tucker K, Kirk J, Hodgson S, Harris M, Douglas F, Lindeman GJ, Zgajnar J, Tischkowitz M, Clowes VE, Susman R, Ramón y Cajal T, Patcher N, Gadea N, Spigelman A, van Os T, Liljegren A, Side L, Brewer C, Brady AF, Donaldson A, Stefansdottir V, Friedman E, Chen-Shtoyerman R, Amor DJ, Copakova L, Barwell J, Giri VN, Murthy V, Nicolai N, Teo SH, Greenhalgh L, Strom S, Henderson A, McGrath J, Gallagher D, Aaronson N, Ardern-Jones A, Bangma C, Dearnaley D, Costello P, Eyfjord J, Rothwell J, Falconer A, Gronberg H, Hamdy FC, Johannsson O, Khoo V, Kote-Jarai Z, Lubinski J, Axcrona … See abstract for full author list ➔ Bancroft EK, et al. Eur Urol. 2014 Sep;66(3):489-99. doi: 10.1016/j.eururo.2014.01.003. Epub 2014 Jan 15. Eur Urol. 2014. PMID: 24484606 Free PMC article.

9

Patient experiences with gene panels based on exome sequencing in clinical diagnostics: high acceptance and low distress.

Sie AS, Prins JB, van Zelst-Stams WA, Veltman JA, Feenstra I, Hoogerbrugge N. Sie AS, et al. Clin Genet. 2015 Apr;87(4):319-26. doi: 10.1111/cge.12433. Epub 2014 Jun 22. Clin Genet. 2015. PMID: 24863757

10

Improving recognition and referral of patients with an increased familial risk of colorectal cancer: results from a randomized controlled trial.

Dekker N, Hermens RP, de Wilt JH, van Zelst-Stams WA, Hoogerbrugge N; RISCO study group. Dekker N, et al. Colorectal Dis. 2015 Jun;17(6):499-510. doi: 10.1111/codi.12880. Colorectal Dis. 2015. PMID: 25524559 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters